Literature DB >> 18616557

In utero exposure to vigabatrin: no indication of visual field loss.

Charlotte Lawthom1, Philip E M Smith, John M Wild.   

Abstract

The purpose of the study was to determine whether in utero exposure to vigabatrin caused visual field loss. Three mothers with four children who had been exposed to vigabatrin in utero and who were subsequently formula fed were identified. All seven individuals underwent perimetry and imaging of the retinal nerve fiber layer (RNFL). All individuals yielded reliable outcomes to perimetry and RNFL images of acceptable quality. Two of the three mothers exhibited vigabatrin-attributed visual field loss and an abnormally attenuated RNFL. The third exhibited an upper left quadrantanopia, consistent with previous temporal lobe surgery, and a normal RNFL. All four children yielded normal visual fields and RNFL thicknesses. The presence of the normal findings for the children is reassuring and, if representative, suggests a lack of vigabatrin visual toxicity and therefore obviates the need for ophthalmological examination of those exposed to vigabatrin prenatally.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18616557     DOI: 10.1111/j.1528-1167.2008.01700.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  5 in total

1.  Evaluating risks for vigabatrin treatment.

Authors:  Gregory L Krauss
Journal:  Epilepsy Curr       Date:  2009 Sep-Oct       Impact factor: 7.500

2.  Epilepsy: Vigabatrin treatment and visual field loss.

Authors:  Catherine Chiron; Olivier Dulac
Journal:  Nat Rev Neurol       Date:  2011-03-01       Impact factor: 42.937

Review 3.  Antiepileptic drugs and pregnancy outcomes.

Authors:  Bogdan J Wlodarczyk; Ana M Palacios; Timothy M George; Richard H Finnell
Journal:  Am J Med Genet A       Date:  2012-06-18       Impact factor: 2.802

Review 4.  Teratogenic effects of antiepileptic drugs.

Authors:  Denise S Hill; Bogdan J Wlodarczyk; Ana M Palacios; Richard H Finnell
Journal:  Expert Rev Neurother       Date:  2010-06       Impact factor: 4.618

5.  A Novel Strategy for Attenuating Opioid Withdrawal in Neonates.

Authors:  Giovanni C Santoro; Samarth Shukla; Krishna Patel; Jakub Kaczmarzyk; Stergiani Agorastos; Sandra Scherrer; Yoon Young Choi; Christina Veith; Joseph Carrion; Rebecca Silverman; Danielle Mullin; Mohamed Ahmed; Wynne K Schiffer; Jonathan D Brodie; Stephen L Dewey
Journal:  J Addict Res Ther       Date:  2016-08-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.